Seeking Alpha

The FDA approves Medtronic's (MDT +0.1%) Advisa DR MRI SureScan pacing system, the company's...

The FDA approves Medtronic's (MDT +0.1%) Advisa DR MRI SureScan pacing system, the company's next-generation pacemaker that enables patients to receive MRI scans, something that is not allowed with traditional pacemakers. It's worth noting that up to 75% of patients with implanted heart devices worldwide are expected to need an MRI scan during the lifetime of those devices. (PR)
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs